105 related articles for article (PubMed ID: 23557520)
1. Successful treatment of rheumatoid vasculitis-associated skin ulcer with a TNF-α antagonist.
Ashida A; Murata H; Mikoshiba Y; Ohashi A; Kobayashi A; Koga H; Uhara H; Okuyama R
Int J Dermatol; 2014 Feb; 53(2):e154-6. PubMed ID: 23557520
[No Abstract] [Full Text] [Related]
2. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
[No Abstract] [Full Text] [Related]
3. Successful treatment of digital tip necrosis in rheumatoid vasculitis with anti-CD20 antibody rituximab.
Korkosz M; Królczyk J; Telesińska-Jasiówka D; Grodzicki T
J Clin Rheumatol; 2013 Jan; 19(1):43-5. PubMed ID: 23319024
[TBL] [Abstract][Full Text] [Related]
4. A Vanishing Entity: Rheumatoid Vasculitis.
Horton J; Kumthekar A
Am J Med; 2018 Nov; 131(11):1310-1313. PubMed ID: 30006132
[No Abstract] [Full Text] [Related]
5. Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis.
Sumida K; Ubara Y; Takemoto F; Takaichi K
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S133. PubMed ID: 21385558
[No Abstract] [Full Text] [Related]
6. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
[No Abstract] [Full Text] [Related]
7. The rapid efficacy of abatacept in a patient with rheumatoid vasculitis.
Fujii W; Kohno M; Ishino H; Nakabayashi A; Fujioka K; Kida T; Nagahara H; Murakami K; Nakamura K; Seno T; Yamamoto A; Kawahito Y
Mod Rheumatol; 2012 Aug; 22(4):630-4. PubMed ID: 22124545
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid vasculitis treated with infliximab.
van der Bijl AE; Allaart CF; Van Vugt J; Van Duinen S; Breedveld FC
J Rheumatol; 2005 Aug; 32(8):1607-9. PubMed ID: 16078342
[TBL] [Abstract][Full Text] [Related]
9. Ulcerative cutaneous sarcoidosis responding to adalimumab.
Philips MA; Lynch J; Azmi FH
J Am Acad Dermatol; 2005 Nov; 53(5):917. PubMed ID: 16243166
[No Abstract] [Full Text] [Related]
10. A case of rheumatoid vasculitis with acquired reactive perforating collagenosis.
Ikeda T; Mikita N; Furukawa F; Iwahashi Y
Mod Rheumatol; 2019 May; 29(3):547-550. PubMed ID: 27846744
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
Guillevin L; Mouthon L
J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
[No Abstract] [Full Text] [Related]
12. ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy.
Simms R; Kipgen D; Dahill S; Marshall D; Rodger RS
Am J Kidney Dis; 2008 Mar; 51(3):e11-4. PubMed ID: 18295046
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vignette: old and new drugs in mixed connective tissue disease.
Rozenbaum M; Slobodin G; Boulman N; Feld J; Avshovich N; Ben-Arieh Y; Rosner I
Isr Med Assoc J; 2008 Nov; 10(11):831-2. PubMed ID: 19070300
[No Abstract] [Full Text] [Related]
14. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
[No Abstract] [Full Text] [Related]
15. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
[No Abstract] [Full Text] [Related]
16. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
Puéchal X; Miceli-Richard C; Mejjad O; Lafforgue P; Marcelli C; Solau-Gervais E; Steinfeld S; Villoutreix C; Trèves R; Mariette X; Guillevin L;
Ann Rheum Dis; 2008 Jun; 67(6):880-4. PubMed ID: 18037625
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis.
Iijima T; Suwabe T; Sumida K; Hayami N; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Sawa N; Takaichi K; Oohashi K; Fujii T; Ubara Y
Mod Rheumatol; 2015 Jan; 25(1):138-42. PubMed ID: 24533557
[TBL] [Abstract][Full Text] [Related]
18. Active tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor.
Fuchs I; Abu-Shakra M; Gelfer E; Smoliakov A; Ben-Haroch D; Horowitz J; Avnon LS
Isr Med Assoc J; 2010 Sep; 12(9):579-81. PubMed ID: 21287806
[No Abstract] [Full Text] [Related]
19. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
20. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Belmonte Serrano MA; Pincus T
Rheumatology (Oxford); 2010 Sep; 49(9):1795-6; author reply 1796-7. PubMed ID: 20484342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
